The program should appeal to basic scientists and clinicians in the fields of neurology, physical medicine and rehabilitation, ophthalmology, otolaryngology, urology, dermatology, aesthetic medicine, gastroenterology, and pain management.
- Review the mechanisms of action and pharmacology of various botulinum neurotoxin serotypes and preparations, in order to be aware of their therapeutic effect
- Evaluate clinical data, evidence-based recommendations, and practical experience in the use of botulinum neurotoxin for multiple and diverse clinical conditions, to properly assess and select appropriate patients for neurotoxin therapy
- Demonstrate procedures and techniques for neurotoxin injections, to improve clinical skills and optimize patient outcomes
- Promote interaction and cooperation among a wide range of scientific and clinical disciplines, to advance research and education relevant to the science and therapeutic application of botulinum and other neurotoxins
ACCME Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine-Montefiore Medical Center and the International Neurotoxin Association (INA). Albert Einstein College of Medicine-Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statement
This activity was planned by and for the healthcare team, and learners will receive 14.5 Interprofessional Continuing Education (IPCE) credits for learning and change.
Albert Einstein College of Medicine-Montefiore Medical Center designates this live activity for a maximum of 14.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Conflict of Interest Statement
The Conflict of Interest Disclosure Policy of Albert Einstein College of Medicine and Montefiore Medical Center requires that faculty participating in any CME activity disclose to the audience any relationship(s) with a pharmaceutical, product, or device company. Any presenter who has disclosed relationships that prove to create a conflict of interest with regard to their contribution to the activity will not be permitted to present.
Albert Einstein College of Medicine-Montefiore Medical Center also requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
AMERICANS WITH DISABILITIES ACT
Albert Einstein College of Medicine-Montefiore Medical Center and the International Neurotoxin Association fully intend to comply with the legal requirements of the Americans with Disabilities Act. If any participant of this activity is in need of special accommodations, please contact the INA at least two weeks prior to the activity at 212-796-0138.
This activity is jointly provided by Albert Einstein College of Medicine-Montefiore Medical Center and International Neurotoxin Association (INA).